Niki BioSolutions, Inc. Operating Cash Flow
Niki BioSolutions, Inc. (NIKI) reported Operating Cash Flow of -$1.84 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-11
- Niki BioSolutions, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$535.72K, a 547.75% decline year-over-year.
- Niki BioSolutions, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$484.28K.
- Niki BioSolutions, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was $119.65K.
- Niki BioSolutions, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$28.49K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | -$535.72K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | -$1.02M derived: sum of 2 quarters · filed 2026-05-11 | -$1.84M S-4/A · filed 2026-05-11 | ||
| 2025-09-30 | -$484.28K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | -$1.30M 6-K · filed 2026-01-22 | |||
| 2025-06-30 | -$816.54K 6-K · filed 2025-10-08 | ||||
| 2024-12-31 | $119.65K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | $91.15K derived: sum of 2 quarters · filed 2026-05-11 | -$1.19M S-4/A · filed 2026-05-11 | ||
| 2024-09-30 | -$28.49K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | -$1.31M 6-K · filed 2026-01-22 | |||
| 2024-06-30 | -$1.28M 6-K · filed 2025-10-08 | ||||
| 2023-12-31 | -$7.72M S-4/A · filed 2026-05-11 | ||||
| 2023-06-30 | -$6.19M 6-K · filed 2024-12-20 | ||||
| 2022-12-31 | -$12.32M 6-K · filed 2025-10-08 | ||||
| 2022-06-30 | -$6.91M 6-K · filed 2023-12-22 | ||||
| 2021-12-31 | -$14.65M 20-F · filed 2024-04-30 | ||||
| 2021-06-30 | -$6.75M 6-K · filed 2022-09-30 | ||||
| 2020-12-31 | -$15.93M 20-F · filed 2023-04-28 | ||||
| 2020-06-30 | -$7.03M 6-K · filed 2021-09-15 | ||||
| 2019-12-31 | -$13.38M 20-F/A · filed 2023-01-17 | ||||
| 2019-06-30 | -$7.34M 6-K · filed 2020-09-02 | ||||
| 2018-12-31 | -$10.04M 20-F · filed 2021-04-19 | ||||
| 2017-12-31 | -$5.78M 20-F · filed 2020-04-29 |